Thyrocare Technologies Management

Management Kriterienprüfungen 2/4

Thyrocare Technologies CEO ist Rahul Guha , ernannt in May 2022, hat eine Amtszeit von 2.5 Jahren. Die jährliche Gesamtvergütung beträgt ₹35.00M , bestehend aus 40% Gehalt und 60% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.1% der Aktien des Unternehmens, im Wert von ₹52.72M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 1.9 Jahre bzw. 2.8 Jahre.

Wichtige Informationen

Rahul Guha

Geschäftsführender

₹35.0m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts40.0%
Amtszeit als Geschäftsführer2.5yrs
Eigentum des Geschäftsführers0.1%
Durchschnittliche Amtszeit des Managements1.9yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder2.8yrs

Jüngste Management Updates

Recent updates

Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are

Oct 31
Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are

Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump

Aug 01
Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump

Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Jul 26
Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)

Jun 12
A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)

Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Feb 29
Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult

Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 04
Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Dec 08
Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly

Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 08
Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems

Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Mar 23
Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively

Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Mar 02
Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First

Feb 01
Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First

Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%

Jan 12
Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%

The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares

Dec 24
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares

Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive

Dec 17
Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive

Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Nov 30
Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Nov 02
Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher

Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates

Nov 01
Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Rahul Guha im Vergleich zu den Einnahmen von Thyrocare Technologies verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

₹840m

Jun 30 2024n/an/a

₹776m

Mar 31 2024₹35m₹14m

₹708m

Dec 31 2023n/an/a

₹655m

Sep 30 2023n/an/a

₹648m

Jun 30 2023n/an/a

₹599m

Mar 31 2023₹32mn/a

₹645m

Vergütung im Vergleich zum Markt: RahulDie Gesamtvergütung ($USD414.68K) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt Indian ($USD359.99K).

Entschädigung vs. Einkommen: RahulDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


Geschäftsführer

Rahul Guha (46 yo)

2.5yrs

Amtszeit

₹35,000,004

Vergütung

Mr. Rahul Franklin Guha serves as President of Operations at API Holdings Limited since 2024. He is Managing Director, Chief Executive Officer and Director of Thyrocare Technologies Limited from May 04, 20...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Rahul Guha
MD, CEO & Chairman2.5yrs₹35.00m0.10%
₹ 52.7m
Alok Jagnani
Chief Financial Officer1.3yrs₹5.55mkeine Daten
K. KallathiKumar
Chief Operating Officerno data₹9.32m0.0030%
₹ 1.6m
Ramjee Dorai
Company Secretary & Compliance Officer10.2yrs₹3.64m0.040%
₹ 20.8m
Pratik Hire
Head of Strategy & Investor Relationsno datakeine Datenkeine Daten
Nitin Chugh
Chief Commercial Officerless than a yearkeine Datenkeine Daten
Aditya Shinde
Vice Presidentno data₹5.33m0.0020%
₹ 1.0m
Kapil Gupta
Strategy Managerno datakeine Datenkeine Daten

1.9yrs

Durchschnittliche Betriebszugehörigkeit

46yo

Durchschnittliches Alter

Erfahrenes Management: THYROCAREDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.9 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Rahul Guha
MD, CEO & Chairman2.5yrs₹35.00m0.10%
₹ 52.7m
Indumati Gopinathan
Non-Executive Independent Director7.3yrs₹240.00kkeine Daten
Dharmil Sheth
Non-Executive & Non-Independent Director3.2yrskeine Datenkeine Daten
Hardik Dedhia
Non Executive Director3.2yrskeine Datenkeine Daten
Dhaval Shah
Non Executive Director3.1yrskeine Datenkeine Daten
Prapti Gilada
Independent Director1.3yrs₹220.00kkeine Daten
Harshil Vora
Non-Executive Independent Director1.3yrs₹40.00kkeine Daten
Anandh Sundar
Independent Directorno datakeine Datenkeine Daten
Nishant Shah
Independent Directorless than a yearkeine Datenkeine Daten

2.8yrs

Durchschnittliche Betriebszugehörigkeit

36yo

Durchschnittliches Alter

Erfahrener Vorstand: THYROCAREDie Vorstandsmitglieder gelten nicht als erfahren ( 2.8 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.